Literature DB >> 16924125

Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia.

Edwin Roger Parra1, Walcy R Teodoro, Ana Paula Pereira Velosa, Cristiane Carla de Oliveira, Natalino Hajime Yoshinari, Vera Luiza Capelozzi.   

Abstract

Recent evidence suggests that type V collagen plays a role in organizing collagen fibrils, thus maintaining fibril size and spatial organization uniform. In this study we sought to characterize the importance of type V collagen morphological disorganization and to study the relationship between type V collagen, active remodeling of the pulmonary vascular/parenchyma (fibroblastic foci), and other collagen types in usual interstitial pneumonia (UIP). We examined type V collagen and several other collagens in 24 open lung biopsies with histological pattern of UIP from patients with idiopathic pulmonary fibrosis (IPF). We used immunofluorescence, morphometry, and three-dimensional reconstruction to evaluate the amount of collagen V and its interaction with the active remodeling progression in UIP, as well as types I and III collagen fibers. Active remodeling progression was significantly related to type V collagen density (p<0.05), showing a gradual and direct increase to minimal, moderate, and severe fibrosis degree in UIP and in the three different areas: normal, intervening, and mural-organizing fibrosis in UIP. Parenchymal changes were characterized by morphological disorganization of fibrillar collagen with diverse disarray and thickness when observed by three-dimensional reconstruction. We concluded that in the different temporal stages of UIP, vascular/parenchyma collagen type V is increased, in disarray, and is the most important predictor of survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16924125      PMCID: PMC3958120          DOI: 10.1369/jhc.6A6969.2006

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  30 in total

1.  Heterogeneous remodeling of lung vessels in idiopathic pulmonary fibrosis.

Authors:  Edwin Roger Parra; Yonara Rivelle David; Lígia Rodrigues Silvério da Costa; Alexandre Ab'Saber; Rogerio Sousa; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro de Carvalho; Mario Terra Filho; Vera Luiza Capelozzi
Journal:  Lung       Date:  2005 Jul-Aug       Impact factor: 2.584

2.  Architectural remodelling in lungs of rabbits induced by type V collagen immunization: a preliminary morphologic model to study diffuse connective tissue diseases.

Authors:  Walcy R Teodoro; Ana P Velosa; Samira S Witzel; Ana L Garippo; Cecília Farhat; Edwin R Parra; Shigueko Sonohara; Vera L Capelozzi; Natalino H Yoshinari
Journal:  Pathol Res Pract       Date:  2004       Impact factor: 3.250

Review 3.  Heterotypic collagen fibrils and stabilizing collagens. Controlling elements in corneal morphogenesis?

Authors:  T F Linsenmayer; J M Fitch; D E Birk
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  The gene encoding collagen alpha1(V)(COL5A1) is linked to mixed Ehlers-Danlos syndrome type I/II.

Authors:  N P Burrows; A C Nicholls; J R Yates; G Gatward; P Sarathachandra; A Richards; F M Pope
Journal:  J Invest Dermatol       Date:  1996-06       Impact factor: 8.551

Review 5.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

Authors:  A L Katzenstein; J L Myers
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

6.  A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis.

Authors:  L C Watters; T E King; M I Schwarz; J A Waldron; R E Stanford; R M Cherniack
Journal:  Am Rev Respir Dis       Date:  1986-01

7.  Type XII and XIV collagens mediate interactions between banded collagen fibers in vitro and may modulate extracellular matrix deformability.

Authors:  T Nishiyama; A M McDonough; R R Bruns; R E Burgeson
Journal:  J Biol Chem       Date:  1994-11-11       Impact factor: 5.157

8.  An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.

Authors:  A C Nicholls; J E Oliver; S McCarron; J B Harrison; D S Greenspan; F M Pope
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

9.  Extracellular matrix in normal and fibrotic human lungs.

Authors:  G Raghu; L J Striker; L D Hudson; G E Striker
Journal:  Am Rev Respir Dis       Date:  1985-02

10.  Tissue-specific expression of the fibril-associated collagens XII and XIV.

Authors:  C Wälchli; M Koch; M Chiquet; B F Odermatt; B Trueb
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

View more
  17 in total

1.  Regulation of Collagen V Expression and Epithelial-Mesenchymal Transition by miR-185 and miR-186 during Idiopathic Pulmonary Fibrosis.

Authors:  Guang-Sheng Lei; Hannah L Kline; Chao-Hung Lee; David S Wilkes; Chen Zhang
Journal:  Am J Pathol       Date:  2016-07-05       Impact factor: 4.307

2.  Association of rs12722 COL5A1 with pulmonary tuberculosis: a preliminary case-control study in a Kazakhstani population.

Authors:  Sanzhar Zhetkenev; Ayauly Khassan; Armanay Khamzina; Alpamys Issanov; Byron Crape; Ainur Akilzhanova; Dauren Yerezhepov; Ulan Kozhamkulov; Chee Kai Chan
Journal:  Mol Biol Rep       Date:  2021-01-07       Impact factor: 2.316

3.  Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis.

Authors:  Jeremy Herrera; Colleen Forster; Thomas Pengo; Angeles Montero; Joe Swift; Martin A Schwartz; Craig A Henke; Peter B Bitterman
Journal:  JCI Insight       Date:  2019-01-10

4.  Hypertonic Saline (NaCl 7.5%) Reduces LPS-Induced Acute Lung Injury in Rats.

Authors:  Ricardo Costa Petroni; Paolo Jose Cesare Biselli; Thais Martins de Lima; Mariana Cardillo Theobaldo; Elia Tamaso Caldini; Rosângela Nascimento Pimentel; Hermes Vieira Barbeiro; Suely Ariga Kubo; Irineu Tadeu Velasco; Francisco Garcia Soriano
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

5.  Adipose-derived stem cells and adipose-derived stem cell-conditioned medium modulate in situ imbalance between collagen I- and collagen V-mediated IL-17 immune response recovering bleomycin pulmonary fibrosis.

Authors:  Renato Gonçalves Felix; Ana Livia Carvalho Bovolato; Ondina Silvia Cotrim; Patricia Dos Santos Leão; Sabrina Setembre Batah; Márjorie de Assis Golim; Ana Paula Velosa; Walcy Teodoro; Vanessa Martins; Fernanda Ferreira Cruz; Elenice Deffune; Alexandre Todorovic Fabro; Vera Luiza Capelozzi
Journal:  Histol Histopathol       Date:  2019-07-18       Impact factor: 2.303

6.  Chronic intermittent hypoxia worsens bleomycin-induced lung fibrosis in rats.

Authors:  Rudolf K Braun; Oleg Broytman; Felix M Braun; Jacqueline A Brinkman; Andrew Clithero; Dhruvangkumar Modi; David F Pegelow; Marlowe Eldridge; Mihaela Teodorescu
Journal:  Respir Physiol Neurobiol       Date:  2017-04-27       Impact factor: 1.931

7.  Association between decreases in type V collagen and apoptosis in mouse lung chemical carcinogenesis: a preliminary model to study cancer cell behavior.

Authors:  Edwin Roger Parra; Leonardo Cavallari Bielecki; José Mauro da Fonseca Pestana Ribeiro; Fernando de Andrade Balsalobre; Walcy R Teodoro; Vera Luiza Capelozzi
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

8.  Detection of V, III and I type collagens of dermal tissues in skin lesions of patients with systemic sclerosis and its implication.

Authors:  Tong Liu; Jian Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10

9.  Autoantibody profile in the experimental model of scleroderma induced by type V human collagen.

Authors:  Maria R M Callado; Vilma S T Viana; Margarete B G Vendramini; Elaine P Leon; Cleonice Bueno; Ana P P Velosa; Walcy R Teodoro; Natalino H Yoshinari
Journal:  Immunology       Date:  2007-04-18       Impact factor: 7.397

10.  Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis.

Authors:  Gisele P Oliveira; Mariana B G Oliveira; Raquel S Santos; Letícia D Lima; Cristina M Dias; Alexandre M Ab' Saber; Walcy R Teodoro; Vera L Capelozzi; Rachel N Gomes; Patricia T Bozza; Paolo Pelosi; Patricia R M Rocco
Journal:  Crit Care       Date:  2009-05-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.